Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scottish life sciences company, Symbiosis Pharmaceutical Services is shifting to Scottish Development International's (SDI) Boston incubator office in the US.
Subscribe to our email newsletter
With the move the company plans to increase its foothold in the US with the help of existing European and US pharmaceutical regulations.
SDI America president Danny Cusick said Symbiosis represents Scottish company that continues to look for new market opportunities overseas in order to grow its business.
"Moving into the SDI incubator in Boston will help them establish a base near to known potential US customers, and act as a springboard to establishing a more permanent presence in the US, ” Cusick added.
Symbiosis founder and chief executive Colin MacKay said both the Stirling facility, Scotland and the operations within it are designed and built to meet the demands in the US market.
"Symbiosis is delighted to be moving into SDI’s Boston incubator as this will provide us with a powerful means of directly accessing the potential market in the US,” MacKay added.
”This step represents another example of how practical, proactive support from Scottish Enterprise and Scottish Development International has directly facilitated the development and growth of Symbiosis both in Scotland and its entry into attractive international markets like the US."